Two Sigma Advisers’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $44.8K | Sell |
|
|||||
|
2023
Q3 | $29.5K | Sell |
|
|||||
|
2023
Q2 | $44.1K | Sell |
|
|||||
|
2023
Q1 | $102K | Sell |
|
|||||
|
2022
Q4 | $215K | Sell |
|
|||||
|
2022
Q3 | $263K | Buy |
|
|||||
|
2022
Q2 | $150K | Buy |
|
|||||
|
2022
Q1 | $133K | Buy |
|
|||||
|
2021
Q4 | $25K | Sell |
|
|||||
|
2021
Q3 | $520K | Buy |
|
|||||
|
2021
Q2 | $279K | Buy |
|
|||||
|
2021
Q1 | $363K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $64K | Buy |
|
|||||
|
2018
Q4 | $36K | Buy |
|